Jeremy Ben-Ami

Jeremy Ben-Ami, founder of J Street and former advisor to President Clinton, debates Einat Wilf, a former Israeli Knesset member and co-author of "The War of Return." They tackle the complex implications of Trump’s policies on Israeli-Palestinian relations amidst the ongoing Gaza war. Wilf argues for Trump’s unwavering support of Israel, while Ben-Ami warns his approach could undermine peace efforts. The conversation dives into the historical significance of U.S. interventions, the challenge of achieving a two-state solution, and the future of Israeli democracy.

Since his 2022 re-election, Israeli Prime Minister Benjamin Netanyahu has introduced plans for a new judiciary reform, leading to large-scale public protests. Supporters say these changes will better balance the power between lawmakers and judges and bring Israel’s judiciary system closer to other countries. Others argue these reforms will undermine the judiciary branch’s independence and affect the country’s relationship with the U.S. and Palestinians. So we debate: Is Netanyahu’s Government Heading in the Wrong Direction? Arguing Yes: Jeremy Ben-Ami, President of J Street and Executive Director of JStreetPac Arguing No: Caroline Glick, Former Senior Contributing and Chief Columnist for the Jerusalem Post and Senior Columnist for Maariv Emmy award-winning journalist John Donvan moderates   Learn more about your ad choices. Visit podcastchoices.com/adchoices

Sen. Chris Van Hollen, Rep. Jamie Raskin, Rep. Jasmine Crockett discuss threats to American democracy, Trump's alignment with dictators, and the importance of defending constitutional values. They also highlight Elise Stefanik's hypocrisy and Texas' restrictive abortion laws. The chapter explores the experiences of women affected by these laws and emphasizes the need for congressional action. The seriousness of the political situation, Trump's plan for autocracy, and the commitment to justice within the American Jewish community are discussed. The chapter concludes with an introduction to XPRIZE's HealthSpan competition that targets biological aging to improve health and well-being.